RELAPSING POLYCHONDRITIS
Clinical trials for RELAPSING POLYCHONDRITIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING POLYCHONDRITIS trials appear
Sign up with your email to follow new studies for RELAPSING POLYCHONDRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cartilage disease: five drugs put to the test
Disease control Recruiting nowThis study tests five different standard immune-suppressing drugs to see which works best for controlling relapsing polychondritis, a rare disease that causes painful inflammation of cartilage. About 20 adults will receive one of the drugs and be monitored for 26 weeks. The goal …
Matched conditions: RELAPSING POLYCHONDRITIS
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Massive study aims to unlock mysteries of rare blood vessel disease
Knowledge-focused Recruiting nowThis study follows up to 4,000 people with vasculitis (a group of diseases that cause blood vessel inflammation) and healthy volunteers over many years. Researchers collect blood, urine, imaging, and genetic samples to learn how the disease develops and changes. The goal is to fi…
Matched conditions: RELAPSING POLYCHONDRITIS
Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study aims to unravel rare cartilage disease
Knowledge-focused Recruiting nowThis study follows 100 people with relapsing polychondritis, a rare disease that causes repeated inflammation of cartilage in the ears, nose, and airways. Researchers will collect medical history and survey data to learn how the disease develops. The goal is to better understand …
Matched conditions: RELAPSING POLYCHONDRITIS
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC